| Jennifer J Peoples, MD | |
|
3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 | |
| (763) 520-5200 | |
| Not Available |
| Full Name | Jennifer J Peoples |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 3300 Oakdale Ave N, Robbinsdale, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669448627 | NPI | - | NPPES |
| 146679800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 45817 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis.
Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.
National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Researchers at North Carolina State University have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA - which may lead to new techniques for manipulating these genetic materials.
› Verified 7 days ago
| Entity Name | North Memorial Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851344907 PECOS PAC ID: 0042123028 Enrollment ID: O20040122000470 |
News Archive
Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis.
Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.
National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Researchers at North Carolina State University have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA - which may lead to new techniques for manipulating these genetic materials.
› Verified 7 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis.
Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.
National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Researchers at North Carolina State University have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA - which may lead to new techniques for manipulating these genetic materials.
› Verified 7 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis.
Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.
National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Researchers at North Carolina State University have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA - which may lead to new techniques for manipulating these genetic materials.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer J Peoples, MD 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5200 | Jennifer J Peoples, MD 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5200 |
News Archive
Vitamin D deficiency is a well reported complication in chronic cholestatic liver disease such as primary biliary cirrhosis. While the prevalence and treatment of this deficiency has been addressed in many articles over the last decades, little is known of the vitamin D status in alcoholic liver cirrhosis.
Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.
National Cheng Kung University (NCKU) in Tainan, southern Taiwan, signed a memorandum of understanding (MOU) with the Ohio State University (OSU) College of Pharmacy on March 20 at the NCKU College of Medicine as part of its effort to enhance its international academic cooperation and most importantly to improve the clinical research on pancreatic cancer.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Researchers at North Carolina State University have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA - which may lead to new techniques for manipulating these genetic materials.
› Verified 7 days ago
Dr. Nayera Rafik Attalla Guirguis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 612-526-1515 Fax: 763-581-8341 | |
Dr. Todd Joseph Stanhope, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5200 Fax: 763-581-8371 | |
Dr. Lisa Erhard, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3366 Oakdale Ave N, Suite 450, Robbinsdale, MN 55422 Phone: 763-587-7000 Fax: 763-587-7015 | |
Eric J Gilster, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3366 Oakdale Ave N, Suite 315, Robbinsdale, MN 55422 Phone: 763-520-7900 Fax: 763-520-7989 | |
Shantel Terese Quinn, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-581-3700 Fax: 763-581-3701 | |
Dr. Daniel P Leafblad, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3366 Oakdale Ave N, #450, Robbinsdale, MN 55422 Phone: 763-257-4400 Fax: 763-520-1791 |